Revenues: | |
Fees from tissue distribution | |
Other revenues | |
Total revenues | 66.55M |
Costs of processing and distribution | 32.27M |
Gross profit | 34.27M |
Expenses: | |
Marketing, general and administrative | 28.72M |
Research and development | 3.79M |
Asset abandonments | |
Total operating expenses | 37.6M |
Operating income | -3.32M |
Other (expense) income: | |
Interest expense | -308K |
Interest income | 1K |
Foreign exchange (loss) gain | -67K |
Total other expense - net | -374K |
Income before income tax provision | |
Income tax provision | 92K |
Net income | |
Net income per common share - basic | -0.08 |
Net income per common share - diluted | -0.08 |
Weighted average shares outstanding - basic | 58.35M |
Weighted average shares outstanding - diluted | 58.35M |